OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Elena Urrestarazu, Jorge Iriarte
Nature and Science of Sleep (2016), pp. 21-21
Open Access | Times Cited: 102
Showing 1-25 of 102 citing articles:
Sleep Disturbance, Cognitive Decline, and Dementia: A Review
Mark N. Wu, Paul B. Rosenberg, Adam P. Spira, et al.
Seminars in Neurology (2017) Vol. 37, Iss. 04, pp. 395-406
Open Access | Times Cited: 228
Mark N. Wu, Paul B. Rosenberg, Adam P. Spira, et al.
Seminars in Neurology (2017) Vol. 37, Iss. 04, pp. 395-406
Open Access | Times Cited: 228
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Chunmei Wang, Qinqin Wang, Bingyuan Ji, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 163
Circadian disruption and sleep disorders in neurodegeneration
Yun Shen, Qian‐Kun Lv, Wei-Ye Xie, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 59
Yun Shen, Qian‐Kun Lv, Wei-Ye Xie, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 59
Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
Mayuri Shukla, Piyarat Govitrapong, Parichart Boontem, et al.
Current Neuropharmacology (2017) Vol. 15, Iss. 7
Open Access | Times Cited: 162
Mayuri Shukla, Piyarat Govitrapong, Parichart Boontem, et al.
Current Neuropharmacology (2017) Vol. 15, Iss. 7
Open Access | Times Cited: 162
Neurodegeneration and the Circadian Clock
Suzanne Hood, Shimon Amir
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 129
Suzanne Hood, Shimon Amir
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 129
Circadian and sleep dysfunction in Alzheimer’s disease
Md. Sahab Uddin, Devesh Tewari, Abdullah Al Mamun, et al.
Ageing Research Reviews (2020) Vol. 60, pp. 101046-101046
Closed Access | Times Cited: 126
Md. Sahab Uddin, Devesh Tewari, Abdullah Al Mamun, et al.
Ageing Research Reviews (2020) Vol. 60, pp. 101046-101046
Closed Access | Times Cited: 126
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 114
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 114
Behavioral and psychological symptoms in Alzheimer's dementia and vascular dementia
William James Deardorff, George T. Grossberg
Handbook of clinical neurology (2019), pp. 5-32
Closed Access | Times Cited: 97
William James Deardorff, George T. Grossberg
Handbook of clinical neurology (2019), pp. 5-32
Closed Access | Times Cited: 97
Circadian Rhythm and Alzheimer’s Disease
Jan Homolak, Monika Mudrovčić, Barbara Vukić, et al.
Medical Sciences (2018) Vol. 6, Iss. 3, pp. 52-52
Open Access | Times Cited: 91
Jan Homolak, Monika Mudrovčić, Barbara Vukić, et al.
Medical Sciences (2018) Vol. 6, Iss. 3, pp. 52-52
Open Access | Times Cited: 91
Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy
Ping‐Tao Tseng, Bing‐Syuan Zeng, Mein‐Woei Suen, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 352-364
Open Access | Times Cited: 25
Ping‐Tao Tseng, Bing‐Syuan Zeng, Mein‐Woei Suen, et al.
Brain Behavior and Immunity (2023) Vol. 111, pp. 352-364
Open Access | Times Cited: 25
Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer’s disease pathology
A. Ahnaou, Diederik Moechars, Leen Raeymaekers, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 85
A. Ahnaou, Diederik Moechars, Leen Raeymaekers, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 85
Achieving brain clearance and preventing neurodegenerative diseases—A glymphatic perspective
Tekla Maria Kylkilahti, Eline Berends, Marta Ramos, et al.
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 9, pp. 2137-2149
Open Access | Times Cited: 48
Tekla Maria Kylkilahti, Eline Berends, Marta Ramos, et al.
Journal of Cerebral Blood Flow & Metabolism (2021) Vol. 41, Iss. 9, pp. 2137-2149
Open Access | Times Cited: 48
Circadian dysfunction and Alzheimer's disease – An updated review
Faizan Ahmad, Punya Sachdeva, Jasmine Sarkar, et al.
Aging Medicine (2022) Vol. 6, Iss. 1, pp. 71-81
Open Access | Times Cited: 32
Faizan Ahmad, Punya Sachdeva, Jasmine Sarkar, et al.
Aging Medicine (2022) Vol. 6, Iss. 1, pp. 71-81
Open Access | Times Cited: 32
Sleep Disorders Associated with Neurodegenerative Diseases
Lucreţia Anghel, Anamaria Ciubară, Aurel Nechita, et al.
Diagnostics (2023) Vol. 13, Iss. 18, pp. 2898-2898
Open Access | Times Cited: 21
Lucreţia Anghel, Anamaria Ciubară, Aurel Nechita, et al.
Diagnostics (2023) Vol. 13, Iss. 18, pp. 2898-2898
Open Access | Times Cited: 21
Sleep deprivation: A risk factor for the pathogenesis and progression of Alzheimer's disease
Zhengyun Han, Xingmao Yang, Shuiqing Huang
Heliyon (2024) Vol. 10, Iss. 7, pp. e28819-e28819
Open Access | Times Cited: 7
Zhengyun Han, Xingmao Yang, Shuiqing Huang
Heliyon (2024) Vol. 10, Iss. 7, pp. e28819-e28819
Open Access | Times Cited: 7
A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease
Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1565-1581
Open Access | Times Cited: 38
Karolina Maciejewska, Kamila Czarnecka, Paweł Szymański
Pharmacological Reports (2021) Vol. 73, Iss. 6, pp. 1565-1581
Open Access | Times Cited: 38
Acoustic stimulation as a promising technique to enhance slow-wave sleep in Alzheimer’s disease: results of a pilot study
Laura Van den Bulcke, Anne-Marie Peeters, Elisabeth R. M. Heremans, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 12, pp. 2107-2112
Open Access | Times Cited: 15
Laura Van den Bulcke, Anne-Marie Peeters, Elisabeth R. M. Heremans, et al.
Journal of Clinical Sleep Medicine (2023) Vol. 19, Iss. 12, pp. 2107-2112
Open Access | Times Cited: 15
Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease
J Kron, Ryan J. Keenan, Daniël Hoyer, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 359-386
Open Access | Times Cited: 15
J Kron, Ryan J. Keenan, Daniël Hoyer, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 359-386
Open Access | Times Cited: 15
The Effects of Light Therapy on Sleep, Agitation and Depression in People With Dementia: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Kenneth N. K. Fong, Xiangyang Ge, K.H. Ting, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2023) Vol. 38
Open Access | Times Cited: 13
Kenneth N. K. Fong, Xiangyang Ge, K.H. Ting, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2023) Vol. 38
Open Access | Times Cited: 13
Role of OX/OXR cascade in insomnia and sleep deprivation link Alzheimer’s disease and Parkinson’s disease: Therapeutic avenue of Dual OXR Antagonist (DORA)
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Siva Prasad Panda, Suman Sinha, Adarsh Kesharwani, et al.
Biochemical Pharmacology (2025), pp. 116794-116794
Closed Access
Role of melatonin supplementation in neurodegenerative disorders
Giovanni Polimeni, Emanuela Esposito, Bevelacqua, et al.
Frontiers in bioscience (2014) Vol. 19, Iss. 3, pp. 429-429
Open Access | Times Cited: 49
Giovanni Polimeni, Emanuela Esposito, Bevelacqua, et al.
Frontiers in bioscience (2014) Vol. 19, Iss. 3, pp. 429-429
Open Access | Times Cited: 49
Living Alone with Alzheimer’s Disease: Data from SveDem, the Swedish Dementia Registry
Pavla Čermáková, Maja Nelson, Juraj Sečník, et al.
Journal of Alzheimer s Disease (2017) Vol. 58, Iss. 4, pp. 1265-1272
Open Access | Times Cited: 46
Pavla Čermáková, Maja Nelson, Juraj Sečník, et al.
Journal of Alzheimer s Disease (2017) Vol. 58, Iss. 4, pp. 1265-1272
Open Access | Times Cited: 46
Circadian Disruption Associated with Alzheimer’s Disease
Yumna Saeed, Sabra M. Abbott
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 4
Closed Access | Times Cited: 45
Yumna Saeed, Sabra M. Abbott
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 4
Closed Access | Times Cited: 45
The management of sleep disorders in dementia
Kirsi M. Kinnunen, Anastasia Vikhanova, Gill Livingston
Current Opinion in Psychiatry (2017) Vol. 30, Iss. 6, pp. 491-497
Closed Access | Times Cited: 42
Kirsi M. Kinnunen, Anastasia Vikhanova, Gill Livingston
Current Opinion in Psychiatry (2017) Vol. 30, Iss. 6, pp. 491-497
Closed Access | Times Cited: 42
Fractal regulation and incident Alzheimer's disease in elderly individuals
Peng Li, Lei Yu, Andrew Lim, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 9, pp. 1114-1125
Open Access | Times Cited: 40
Peng Li, Lei Yu, Andrew Lim, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 9, pp. 1114-1125
Open Access | Times Cited: 40
